---
figid: PMC11513379__fphar-15-1434994-g002
figtitle: Nanomedicine in HNSCC therapy-a challenge to conventional therapy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11513379
filename: fphar-15-1434994-g002.jpg
figlink: /pmc/articles/PMC11513379/figure/F2/
number: F2
caption: The EGFR signaling pathway, PI3K/AKT/mTOR pathway, MAPK pathway, STAT pathway,
  and MET pathway in head and neck cancer
papertitle: Nanomedicine in HNSCC therapy-a challenge to conventional therapy
reftext: Chenyu Li, et al. Front Pharmacol. 2024;15(NA).
year: '2024'
doi: 10.3389/fphar.2024.1434994
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: head and neck cancer | molecular pathogenesis | nano-drug | nanocarrier
  and delivery | cancer
automl_pathway: 0.9690234
figid_alias: PMC11513379__F2
figtype: Figure
redirect_from: /figures/PMC11513379__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11513379__fphar-15-1434994-g002.html
  '@type': Dataset
  description: The EGFR signaling pathway, PI3K/AKT/mTOR pathway, MAPK pathway, STAT
    pathway, and MET pathway in head and neck cancer
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFA
  - EGF
  - EGFR
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - SRC
  - FGR
  - FYN
  - YES1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - ERBB2
  - IGF1R
  - RAPGEF5
  - PTEN
  - KRAS
  - HRAS
  - NRAS
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - KDR
  - FLT1
  - FLT4
  - RET
  - PLCG1
  - PLCG2
  - STAT3
  - STAT5A
  - STAT5B
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K6
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PAK1
  - PKN1
  - DNMT1
  - AREG
  - HBEGF
  - BTC
  - EREG
  - EPGN
  - MTOR
  - EPHB2
  - MAPK3
  - DUSP5
  - DUSP1
  - DUSP2
  - DUSP3
  - DUSP4
  - DUSP6
  - NOS2
  - ISYNA1
  - COX2
  - PTGS2
  - MTCO2P12
  - E2F1
  - UBE2L3
  - PCNA
  - PRKDC
  - PGE2
  - Carcinogens
  - EGF
  - RAS
  - MEK
---
